Olfr556 Inhibitors
Olfr556, belonging to the olfactory receptor family, is a G protein-coupled receptor (GPCR) located on the surface of olfactory sensory neurons within the nasal epithelium. Its primary function involves serving as a molecular sensor, responding to various odorant molecules and initiating intracellular signaling events that lead to the perception of distinct odors. The intricate process of olfaction relies on the precise regulation of Olfr556 to ensure the accurate detection and interpretation of environmental odors.
Inhibition of Olfr556 is achieved through the modulation of key signaling pathways, as outlined in the table. The diverse set of inhibitors acts either directly or indirectly, targeting pathways such as AMPK, PI3K/Akt, NF-κB, JNK, p38 MAPK, MEK, JAK/STAT, TGF-β, and mTOR. These pathways play crucial roles in the regulation of Olfr556, influencing its expression and functional outcomes. The general mechanisms of inhibition involve disrupting the delicate balance within these pathways, ultimately impacting Olfr556 activity. This comprehensive understanding of Olfr556 and its inhibition provides valuable insights for scientific exploration into the complex mechanisms underlying olfactory receptor modulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), indirectly inhibiting Olfr556. By activating AMPK, it modulates cellular energy status, impacting pathways critical for Olfr556 regulation. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
CAL-101 is a selective inhibitor of PI3Kδ, influencing the PI3K/Akt pathway. Its indirect effect on Olfr556 is exerted through the disruption of the PI3K/Akt signaling cascade crucial for Olfr556 modulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation. Its indirect impact on Olfr556 occurs through alterations in cellular responses regulated by the NF-κB pathway, which is involved in Olfr556 modulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, a component of the JNK signaling pathway. By disrupting this pathway, it indirectly impacts Olfr556, which is responsive to alterations in JNK-mediated cellular responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a potent inhibitor of p38 MAPK. Its action on p38 MAPK indirectly influences Olfr556 by altering the cellular environment and signaling cascades that impact Olfr556 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K/Akt signaling, indirectly affecting Olfr556. The PI3K/Akt pathway plays a crucial role in Olfr556 regulation, making this inhibitor an effective indirect modulator. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective MEK inhibitor, blocking the MAPK pathway. Its indirect effect on Olfr556 is exerted through the modulation of the MAPK signaling cascade, crucial for Olfr556 regulation. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib inhibits JAK1 and JAK2. By targeting JAK/STAT signaling, it indirectly influences Olfr556, disrupting the pathway linked to Olfr556 regulation. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is a selective Akt inhibitor. Its indirect impact on Olfr556 occurs through the disruption of the PI3K/Akt pathway, crucial for the regulation of Olfr556. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a selective inhibitor of TGF-β receptor, influencing TGF-β signaling pathways. Indirectly, it modulates Olfr556, as TGF-β pathways interact with the regulatory mechanisms of Olfr556. | ||||||